新天药业
(002873)
| 流通市值：17.67亿 | | | 总市值：17.99亿 |
| 流通股本：2.40亿 | | | 总股本：2.44亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 503,491,479.47 | 331,825,486.07 | 178,610,160.01 | 749,720,071.32 |
| 营业收入 | 503,491,479.47 | 331,825,486.07 | 178,610,160.01 | 749,720,071.32 |
| 二、营业总成本 | 493,174,209.07 | 325,225,898.53 | 174,084,468.5 | 744,175,673.38 |
| 营业成本 | 135,932,446.13 | 89,515,773.59 | 49,127,083.34 | 213,074,541.32 |
| 税金及附加 | 12,527,808.98 | 7,123,955.77 | 5,030,854.44 | 14,190,460.81 |
| 销售费用 | 212,197,096.01 | 141,155,307.92 | 76,866,163.79 | 328,797,168.63 |
| 管理费用 | 90,337,357.28 | 57,900,618.92 | 29,310,706.43 | 127,908,162.42 |
| 研发费用 | 29,265,471.26 | 20,727,936.45 | 9,304,365.07 | 42,554,033.91 |
| 财务费用 | 12,914,029.41 | 8,802,305.88 | 4,445,295.43 | 17,651,306.29 |
| 其中:利息费用 | 12,937,404.98 | 8,857,921.09 | 4,499,983.7 | 17,759,705.67 |
| 其中:利息收入 | 213,832.64 | 175,872.58 | 95,663.4 | 416,217.25 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -36,009.78 | -36,009.78 | -7,100.52 | -21,808.74 |
| 加:投资收益 | 136,557.51 | 112,264.15 | - | 6,728.87 |
| 资产处置收益 | 3,387,710.8 | - | - | -781,861.48 |
| 资产减值损失(新) | -1,829,943.12 | -2,042,045.71 | -1,089,608.94 | -3,597,009.59 |
| 信用减值损失(新) | 2,344,251.18 | 1,705,234 | 600,117.48 | 2,000,257.91 |
| 其他收益 | 3,738,641.88 | 1,942,962.28 | 1,199,945.85 | 6,920,327.06 |
| 四、营业利润 | 18,058,478.87 | 8,281,992.48 | 5,229,045.38 | 10,071,031.97 |
| 加:营业外收入 | 93,632.35 | 86,328.36 | 31,780.55 | 58,531.12 |
| 减:营业外支出 | 302,992.38 | 159,846.27 | 15,376.86 | 360,106.48 |
| 五、利润总额 | 17,849,118.84 | 8,208,474.57 | 5,245,449.07 | 9,769,456.61 |
| 减:所得税费用 | 1,143,428 | 3,347,038.35 | 1,750,275.95 | 657,980.8 |
| 六、净利润 | 16,705,690.84 | 4,861,436.22 | 3,495,173.12 | 9,111,475.81 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 16,705,690.84 | 4,861,436.22 | 3,495,173.12 | 9,111,475.81 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 16,705,690.84 | 4,861,436.22 | 3,495,173.12 | 9,111,475.81 |
| 扣除非经常损益后的净利润 | 11,907,205.33 | 3,984,397.54 | 3,009,913.8 | 5,335,961.65 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.07 | 0.02 | 0.01 | 0.04 |
| (二)稀释每股收益 | 0.07 | 0.02 | 0.01 | 0.04 |
| 八、其他综合收益 | - | - | - | 66,535,046.25 |
| 归属于母公司股东的其他综合收益 | - | - | - | 66,535,046.25 |
| 九、综合收益总额 | 16,705,690.84 | 4,861,436.22 | 3,495,173.12 | 75,646,522.06 |
| 归属于母公司股东的综合收益总额 | 16,705,690.84 | 4,861,436.22 | 3,495,173.12 | 75,646,522.06 |
| 公告日期 | 2026-10-29 | 2026-08-26 | 2026-04-30 | 2026-03-31 |
| 审计意见(境内) | | | | 标准无保留意见 |